License to Allergan. In addition, in the event that Allergan provides ASTI with a Reversion Notice (as such term is defined in Section 2.4 of the Research and Development Agreement) with respect to a Pre-Selection Product, ASTI hereby grants to Allergan, effective upon the date of such Reversion Notice, a worldwide, exclusive (even as to ASTI), perpetual license, with the right to sublicense, to conduct research and development with respect to such Pre-Selection Product and to make, have made, use, sell, have sold, import and export such Pre-Selection Product, subject to Allergan's obligation to pay Pre-Selection Product Payments and Developed Technology Royalties (as such terms are defined in the Research and Development Agreement).
Appears in 3 contracts
Samples: Technology License Agreement (Allergan Specialty Therapeutics Inc), Technology License Agreement (Allergan Inc), Technology License Agreement (Allergan Inc)
License to Allergan. In addition, in the event that Allergan provides ASTI with a Reversion Notice (as such term is defined in Section 2.4 of the Research and Development Agreement) with respect to a Pre-Selection Product, ASTI hereby grants to Allergan, effective upon the date of such Reversion Notice, a worldwide, exclusive (even as to ASTI), perpetual license, with the right to sublicense, to conduct research and development with respect to such Pre-Selection Product and to make, have made, use, sell, have sold, import and export such Pre-Selection Product, subject to Allergan's obligation to pay Pre-Selection Product Payments and Developed Technology Royalties (as such terms are as defined in the Research and Development Agreement).
Appears in 1 contract
Samples: Technology License Agreement (Allergan Specialty Therapeutics Inc)